Picture of Bioatla logo

BCAB — Bioatla News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapNeutral

Bioatla Inc expected to post a loss of 67  cents a share - Earnings Preview

* Bioatla Inc  BCAB.OQ   BCAB.O  is expected to show a rise
in
quarterly revenue when it reports  results on May 4. 
    * The San Diego California-based  company is expected to
report
revenue of $375 thousand, according to the mean estimate from 4
analysts, based on Refinitiv data.  
    * ​Refinitiv's mean analyst estimate for Bioatla Inc is for
a loss
of 67 cents per share. For the same quarter last year, the
company reported a loss of 56 cents per share.
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 5 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts had risen by
about 2.8%
in the last three months. ​
    * Wall Street's median 12-month price target for Bioatla Inc
is
$44​, above​ its last closing price of $3.68. ​​​
    * Previous quarterly performance (using preferred earnings
measure
in US dollars). ​

 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Dec. 31 2021  -0.63       -0.63      -0.62     Beat    1.2
 Sep. 30 2021  -0.63       -0.64      -0.68     Missed  -5.7
 Jun. 30 2021  -0.60       -0.58      -0.90     Missed  -53.9​
 Mar. 31 2021  -0.49       -0.52      -0.56     Missed  -7.1
 ​​Dec.        -0.78       -0.78      -1.50     Missed  -92.6
 31 2020                                                
                                                        ​
 This summary was machine generated May 3 at 02:10 GMT.  All
figures in US dollars  unless otherwise stated

Recent news on Bioatla

See all news